1991
DOI: 10.1159/000235434
|View full text |Cite
|
Sign up to set email alerts
|

Survey of Hanganutziu and Deicher Antibodies in Operated Patients

Abstract: The appearance of Hanganutziu and Deicher (HD) antibody in the sera of patients suffering from various diseases, including malignancies of some organs and liver disorders, was investigated by enzyme-linked immunosorbent assay using N-glycolylneuraminyl-lactosylceramide (HD3) and 4-O-acetyl-HD3 as the antigenic molecules. More than 25% of sera from patients suffering from malignancies, cholelithiasis and liver cirrhosis had HD antibody, whereas none of 41 sera from healthy persons had HD antibody. The percentag… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
22
0

Year Published

1994
1994
2016
2016

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(22 citation statements)
references
References 7 publications
0
22
0
Order By: Relevance
“…While this article was in preparation, another group independently reported a high prevalence of anti-Neu5Gc antibodies in normal human sera, using a different approach (39). The findings of both studies stand in contrast to previous reports of the prevalence of anti-Neu5Gc antibodies in normal humans, ranging only from 0-10% for the IgG class to 3.8-13.8% for the IgM class (40)(41)(42). This disparity can be explained by the greater sensitivity and lower background of the assays we used, the use of an optimal control target (identical except for Neu5Ac in place of Neu5Gc), and the checks for specificity (blockade by chimpanzee but not human serum, or by free Neu5Gc but not free Neu5Ac).…”
Section: Discussionmentioning
confidence: 64%
See 1 more Smart Citation
“…While this article was in preparation, another group independently reported a high prevalence of anti-Neu5Gc antibodies in normal human sera, using a different approach (39). The findings of both studies stand in contrast to previous reports of the prevalence of anti-Neu5Gc antibodies in normal humans, ranging only from 0-10% for the IgG class to 3.8-13.8% for the IgM class (40)(41)(42). This disparity can be explained by the greater sensitivity and lower background of the assays we used, the use of an optimal control target (identical except for Neu5Ac in place of Neu5Gc), and the checks for specificity (blockade by chimpanzee but not human serum, or by free Neu5Gc but not free Neu5Ac).…”
Section: Discussionmentioning
confidence: 64%
“…Some other diseases such as hepatitis, liver cirrhosis, infectious mononucleosis, rheumatoid arthritis, syphilis, and lepromatous leprosy are claimed to be associated with ''Hanganutziu-Deicher'' heterophile anti-Neu5Gc antibodies (40)(41)(42). Such antibodies could play a role in initiation or progression or simply arise from immune dysregulation that allows preexisting memory B cells to expand.…”
Section: Discussionmentioning
confidence: 99%
“…These sugar nucleotides are the high energy donors necessary for the addition of sialic acid to glycoconjugates in the Golgi apparatus. Neu5Gc is found in large amounts in all mammals except humans, in whom it is even antigenic (21)(22)(23). Humans are evolutionarily most closely related to the African great apes, sharing nearly 99% genetic identity with Pan troglodytes (the chimpanzee) and Pan paniscus (the bonobo) and a somewhat lesser identity with Gorilla gorilla (the gorilla) and Pongo pygmaeus (the orangutan) (24 -30).…”
mentioning
confidence: 99%
“…They are called Hanganutziu and Deicher (HD) antigens. Cancer patients occasionally generate high-titre antibodies against HD antigens [9][10][11]. Chickens with Marek's disease lymphoma also express Neu5Gc [12] and the fact that chickens lack Neu5Gc was confirmed by the production of high-titre antibody in chickens immunized with Neu5Gc-containing gangliosides [13].…”
Section: Introductionmentioning
confidence: 99%